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ABSTRACT 25 
 26 
Objectives: In primary aldosteronism (PA), adrenal vein sampling (AVS) suggests unilateral 27 
aldosterone-producing adenoma (APA) when the aldosterone/cortisol (A/F) ratio is ≤ 28 
peripheral on one side and ≥2 times peripheral on the other.  When A/F ratios are lower 29 
bilaterally than peripheral despite adequate samples (adrenal venous cortisol ≥3 times 30 
peripheral), we recommend repeat AVS.  This study aimed to determine the frequency of this 31 
occurrence and outcomes in such cases. 32 
Methods: We performed a retrospective observational study of all cases of primary 33 
aldosteronism undergoing initial AVS over a 34 year period.  34 
 Results: Initial AVS in 1397 patients returned satisfactory, discriminatory results in 1066 35 
(76.3%) but 37 patients (2.6%) had adequate samples but bilateral A/F ratios no higher than 36 
peripheral. Of the 22 of these 37 who agreed to repeat AVS, 10 demonstrated unilateral 37 
aldosterone production, and eight of these had unilateral adrenalectomy disclosing APAs and 38 
resulting in cure (3) or improvement (5) in hypertension. Eight had bilateral aldosterone 39 
production. Four studies were inconclusive. Patients with initial unsatisfactory AVS because 40 
of bilaterally low A/F ratios had significantly (p=0.023) more unilateral disease [10 of 18 41 
satisfactory repeat studies (55.6%) vs 326 of 1066 satisfactory initial studies (30.6%)] and a 42 
significantly higher (67.6% vs. 49.9%, p=0.034) percentage of males.  43 
Conclusions: Since the incidence of APAs was high in a subgroup with low A/F bilaterally 44 
on initial AVS, these patients should be offered repeat AVS. This might reflect both a greater 45 
dependence of aldosterone production on ACTH in APAs and the pulsatile nature of ACTH 46 
secretion.  47 
Key Words: 48 
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INTRODUCTION 50 
Recognition of higher than previously expected rates of primary aldosteronism (PA) among 51 
hypertensives [1,2] was a major stimulus for the  creation by The Endocrine Society in 2008 52 
of international guidelines for case detection and investigation of PA [3]. Adrenal venous 53 
sampling (AVS) is important in the diagnostic process, distinguishing unilateral from 54 
bilateral aldosterone overproduction, with additional treatment options. AVS  is a challenging 55 
procedure, requiring an experienced radiologist, and reported rates of successful cannulation 56 
of both adrenal veins vary from 42% to 98% [4,5]. Cannulating the right adrenal vein is 57 
frequently more difficult than the left, due to the small vessel size and its direct entry into the 58 
inferior vena cava, while the left adrenal vein usually joins the left phrenic vein which drains 59 
into the left renal vein. Confirmation of successful catheter placement requires comparison of 60 
adrenal and peripheral venous cortisol levels in order to correct for dilution from non-adrenal 61 
blood, with adrenal vein/peripheral vein cortisol ratios of at least 3.0 indicating satisfactory 62 
catheter placement [6]. Aldosterone/cortisol (A/F) ratios are then compared between adrenal 63 
and peripheral samples in order to differentiate unilateral from bilateral adrenal aldosterone 64 
overproduction, the former suggested by an A/F ratio lower than peripheral on one side 65 
(contralateral suppression) and an A/F ratio on the other side at least two-fold higher than 66 
peripheral [6]. 67 
Fortunately only rarely, in our experience, A/F ratios bilaterally are found to be no higher 68 
than peripheral, despite cortisol gradients confirming successful adrenal vein cannulation, a 69 
result that is uninterpretable in regard to lateralisation of aldosterone production. The 70 
frequency of this occurrence, the best subsequent management and the likely outcomes have 71 
to our knowledge never been documented. The aim of this study therefore was to 72 
retrospectively analyse our AVS database to identify such cases of primary aldosteronism 73 
where adequate cannulation of both adrenal veins was demonstrated but no increase in the 74 
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A/F ratio on either side found during adrenal vein sampling. We further examined these cases 75 
to identify the results of further testing and outcomes. 76 
 77 
METHODS 78 
Setting and subjects 79 
This study was performed in the Hypertension Units of the Greenslopes and Princess 80 
Alexandra Hospitals, Brisbane, Australia. Using a prospectively updated database, results of 81 
AVS between January 1978 and February 2012 were searched for those with bilaterally low 82 
A/F ratios on initial sampling.  83 
Diagnosis of primary aldosteronism 84 
The diagnosis of PA was established according to our previously published criteria [7]. 85 
Interfering medications (diuretics, beta blockers, angiotensin converting enzyme inhibitors, 86 
angiotensin II receptor antagonists and dihydropyridine calcium channel antagonists) were 87 
stopped, if possible, at least 4 weeks prior to testing (6 weeks in the case of diuretics 88 
including spironolactone). Patients with an elevated aldosterone/renin ratio on at least 2 89 
occasions (>70 with plasma aldosterone in picomoles/liter and plasma active renin in 90 
milliunits/liter or >590 with plasma renin activity in ng/ml/hr) underwent fludrocortisone 91 
suppression testing to confirm PA. Fludrocortisone suppression testing was regarded as 92 
positive if the aldosterone level at 10:00 am after at least 2 hours of upright posture was 93 
≥165pmol/L after 4 days of oral salt loading with concurrent fludrocortisone administration 94 
(0.1mg 6 hourly), providing that (1) upright renin was suppressed to less than 8.4mU/L, (2) 95 
plasma potassium was within the normal range  (sufficient oral potassium chloride 6 hourly 96 
to keep plasma potassium measured at least three times daily as close as possible to 97 
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4.0mmol/L) and (3) plasma cortisol was lower at 1000 h than at 0800h, excluding an acute 98 
increase in ACTH preventing suppression of aldosterone. 99 
Adrenal vein sampling 100 
This study was restricted to those in whom bilateral adrenal vein cannulation was attempted. 101 
Adrenal vein sampling was performed between 8 and 11am after overnight recumbency and 102 
without ACTH stimulation.  Sequential cannulation of both adrenal veins was performed by 103 
no more than three experienced radiologists in either hospital (six in total). Usually a short 104 
time (<15mins) elapsed between sampling of the left and right adrenal veins. Gradients of ≥3 105 
between adrenal and peripheral venous cortisol concentrations were taken to indicate 106 
adequate sampling. If the A/F ratio on one side was ≥2 times the simultaneously collected 107 
peripheral ratio and on the other side was the same or less than peripheral (contralateral 108 
suppression), the study was considered to demonstrate lateralization of aldosterone 109 
production. Adrenal venous A/F ratios higher than peripheral on both sides were taken to 110 
indicate bilateral aldosterone production. When results of AVS were inconclusive 111 
(comprising unsuccessful cannulation of either adrenal vein or A/F ratios no higher than 112 
peripheral bilaterally), repeat AVS was offered to the patient. Computed tomography (CT) of 113 
the adrenals with slices 2-3 mm apart was always performed prior to adrenal vein sampling in 114 
order to identify any adrenal lesions and to localize adrenal veins and thus assist in successful 115 
cannulation [5]. 116 
Outcomes 117 
Hospital records were examined to determine patient outcome.  Data were collected on 118 
patient demographic details, AVS results, serum potassium on presentation and follow up, 119 
blood pressure and medications before and after unilateral adrenalectomy or commencement 120 
of aldosterone blocking medications. 121 
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Hypertension was defined as ‘cured’ if BP was 140/90 mm Hg or less without 122 
antihypertensive medications and ‘improved’ if fewer medications were needed, provided 123 
that the dosage of none of the medications was increased, or if the dosage of one or more 124 
medications could be reduced, provided that no additional medications were added. Patients 125 
were regarded as ‘not improved’ if the same or a greater number or antihypertensives were 126 
needed to achieve the same BP or if the BP was higher. When patients had a repeat FST after 127 
unilateral adrenalectomy (commencing February 1996), demonstration of normal 128 
suppressiblity of aldosterone was taken to indicate biochemical cure of PA [8]. 129 
Statistics 130 
The data were analysed using Statistica 10 (Statsoft. Inc Tulsa).Standard descriptive statistics 131 
were employed for demographic data. For non-parametrically distributed data medians were 132 
compared using the Mann-Whitney U test. Proportions between groups were compared using 133 
the chi-square test. A “p” value <0.05 was considered statistically significant. 134 
 135 
RESULTS  136 
Patient characteristics and frequency of bilateral low A/F ratios. 137 
Of 1397 patients with PA who underwent an initial AVS, 37 (2.6%) had adrenal venous A/F 138 
ratios the same or lower than peripheral on both sides. Of the remaining initial studies, 1066 139 
were conclusive and 294 (21%) were inconclusive. 140 
The demographics, results of CT examination, presence of pre-treatment hypokalemia, results 141 
of repeat AVS, histology and outcomes in terms of BP and repeat fludrocortisone suppression 142 
testing (if performed) after unilateral adrenalectomy for the 37 patients are shown in table 1. 143 
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There was a significantly (p=0.034) higher percentage of males among the 37 with low A/F 144 
ratios bilaterally than among the remaining patients undergoing AVS [25/37 (67.6%) vs. 145 
679/1360 (49.9%)]. Median ages were similar (54.0 vs 53.5 years, p=0.38). 146 
Outcomes  147 
While 15 patients declined a repeat study, 22 of the 37 patients with bilaterally low initial 148 
A/F ratios underwent repeat AVS. Ten of these were consistent with unilateral and eight with 149 
bilateral aldosterone production. Four studies were again inconclusive, two due to failure to 150 
successfully cannulate one or both adrenal veins and two due to bilateral low A/F ratios for a 151 
second time. 152 
A similar proportion of those who declined repeat AVS compared to those who repeated 153 
AVS had hypokalemia (9/15 vs. 11/22 p=0.55), evidence of adrenal adenoma on CT where 154 
available (8/12 vs. 12/19 p=0.82), and were of male gender (9/15 vs 16/22 p=0.42). 155 
Eight of the ten patients showing unilateral aldosterone production went on to unilateral 156 
adrenalectomy. Four of the five who had follow-up FST had a biochemical cure and the fifth 157 
had residual but reduced unsuppressible aldosterone production. The five who had been 158 
hypokalemic became normokalemic, and hypertension was cured in three and improved in 159 
the other five. 160 
The possibility of unilateral APA was considered and discussed with five additional patients 161 
with unsatisfactory initial AVS on the basis of a unilateral mass lesion on CT and 162 
hypokalaemia (patients 19, 23, 24, 25 and 26). Four had declined a second AVS and one had 163 
an inconclusive second AVS.  They all chose unilateral adrenalectomy. Two had a follow up 164 
FST which confirmed biochemical cure. Hypertension was cured in two and improved in 165 
three. 166 
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When repeat AVS was consistent with bilateral aldosterone production (n=8), specific 167 
medical treatment was commenced with either spironolactone or amiloride or both, with 168 
correction of hypokalemia in the four initially hypokalemic and improvement of hypertension 169 
in all. Three of these patients eventually went on to unilateral adrenalectomy because of a 170 
poor long term blood pressure response or intolerance to medical therapy. In these cases the 171 
side with higher aldosterone production was removed. 172 
There was a significantly higher frequency of unilateral disease (10/18 [55.6%] vs. 326/1066 173 
[30.6%], p=0.023) in the subgroup with bilaterally low A/F on initial AVS than in the 1066 174 
with initial diagnostic AVS. 175 
 176 
DISCUSSION 177 
As far as we are aware, this is the first report suggesting that repeat AVS in cases where the 178 
initial study was compromised by bilateral low adrenal venous A/F ratios yields a high 179 
incidence of unilateral PA with worthwhile clinical and biochemical responses to unilateral 180 
adrenalectomy. A higher percentage of males in this subgroup was an additional unexpected 181 
finding. 182 
There is no immediately obvious explanation for the higher incidence of unilateral disease in 183 
the PA patients with failed AVS due to bilaterally quiescent secretion of aldosterone. ACTH 184 
is secreted episodically in pulses, reflected in the pattern of cortisol levels revealed by 185 
frequent, 20 minute sampling [9].  Aldosterone secretion in patients with APA has been 186 
shown to have an episodic or pulsatile pattern of release, and it has been suggested that this is 187 
more “disorderly” than in normal subjects [10]. While it has been suggested that APAs are 188 
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more responsive to ACTH than the adrenals of patients with bilateral overproduction of 189 
aldosterone [11,12], there is also published evidence contradicting this [13].  190 
If renin-angiotensin is chronically severely suppressed in PA, which happens more 191 
commonly in APA than in bilateral PA, then responses to other regulators such as ACTH and 192 
potassium may become more prominent and recognisable. Secretion normally resulting from 193 
angiotensin stimulation will be minimal, significantly lowering adrenal venous 194 
concentrations, so that any periods of quiescence in episodic ACTH secretion will be 195 
accompanied by very low aldosterone secretion and be more recognisable. This is perhaps 196 
what we are seeing in the patients with failed AVS despite good cannula placement, and 197 
might explain why more of them than expected have unilateral APAs.   198 
Errors arising during assay of aldosterone and cortisol can never be completely excluded but 199 
evidence to suggest this was not found in the cases in question.  Explanations such as 200 
anomalous venous drainage of the adrenals [5,14–16], accidental ‘super-selective’ adrenal 201 
sampling [17], or extra-adrenal aldosterone producing tumours are unlikely given the results 202 
of repeat AVS. 203 
The preponderance of males in those with bilaterally low A/F ratios during AVS is an 204 
unexpected finding and has no obvious explanation. Possibly this was a chance finding due to 205 
the small number of cases.  206 
A significant limitation of this study is its retrospective nature which, for example, may have 207 
increased the risk of selection bias when considering subjects for repeat AVS. The 208 
percentages of patients with adrenal lesions on CT and/or with hypokalemia in the sub-209 
groups accepting repeat AVS and those not accepting were not different. This makes it 210 
improbable that stronger arguments in favour of repeat AVS were used for those thought at 211 
the time more likely to have an APA. 212 
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The principal finding in the present study was that, despite failure of the initial AVS to 213 
contribute to a diagnosis, repeat AVS was usually successful. Eighteen of 22 repeat AVS 214 
were diagnostic. This is perhaps surprising, and suggests that the initial sampling during 215 
quiescent aldosterone secretion was presumably due to chance (and episodic ACTH 216 
secretion) rather than a permanent idiosyncratic particularity of adrenal function in these 217 
patients. 218 
Some units employ ACTH stimulation of aldosterone secretion with an intravenous bolus 219 
immediately before, or a continuous infusion during, AVS sampling [18,19].  The aim is to 220 
maximise the sensitivity of the procedure, ensuring active secretion of both cortisol and 221 
aldosterone by both adrenals during sample collection. Rossi et al reported that an ACTH 222 
bolus (250mcg) before AVS consistently increased aldosterone production by the 223 
contralateral adrenal but less consistently from the ipsilateral APA, reducing successful 224 
lateralization [20]. The same group studied varied bolus doses of ACTH, reporting a 225 
favourable increase in the “selectivity index” with higher doses of ACTH, but again 226 
counterbalanced, unfortunately, by a confounding effect on correct lateralisation of APA 227 
[21]. There has been some criticism of this study because of unusually permissive criteria for 228 
successful sampling and lateralisation [22]. A multicentre study (three Units, 76 patients) 229 
employing either ACTH bolus or infusion found that ACTH stimulation increased rates of 230 
successful bilateral cannulation from 49% to 87%, without significantly reducing accuracy of 231 
discrimination between unilateral and bilateral disease [23]. 232 
While we cannot answer the question whether ACTH stimulation during AVS would have 233 
reduced the already low incidence of bilaterally quiescent aldosterone secretion, it is 234 
reasonable to suggest that it might have. We have therefore recently changed our protocol for 235 
repeat AVS only, following bilateral low adrenal vein/peripheral vein aldosterone/cortisol 236 
ratios at initial AVS. This involves collection of two full sets of samples, the first without 237 
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ACTH stimulation and the second with ACTH stimulation. If the first samples without 238 
ACTH stimulation are satisfactory, those results are accepted as definitive, since any possible 239 
compromise due to loss of contralateral suppression following ACTH stimulation is avoided.  240 
The additional samples collected after ACTH are only utilised in diagnosis if those before 241 
ACTH again showed low aldosterone cortisol ratios versus peripheral bilaterally.  242 
To conclude, in this study we examined an infrequent but difficult clinical problem; when, 243 
despite unequivocal evidence of primary aldosteronism, adrenal vein sampling fails to 244 
demonstrate elevated aldosterone/cortisol ratios on either side.  It appears that persistence in 245 
pursuing a diagnosis in this group yields unexpectedly high rates of potentially curable APA. 246 
It seems likely that the problem is associated with quiescent periods in ACTH secretion, 247 
which may be more common in males than females. We recommend always encouraging the 248 
patient to have repeat AVS in this situation. We are prospectively examining the use of 249 
ACTH stimulation in repeat studies, with sampling both before and after ACTH. 250 
 251 
  252 
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Table 1. Demographic details and outcomes in patients with bilaterally low A/F ratios on initial AVS 253 
Patient Age at 
diagnosis 
(y) 
Gender Result of second 
attempt at 
AVS* 
Nodule on 
Adrenal CT
+
 
Hypokalemia Treatment
#
 Blood pressure 
outcome 
Tumor 
size (cm)
×
 
Post op 
FST
†
 
1 63 M Right Y N Adrenalectomy Improved 1.1 - 
2 43 M Right Y Y Adrenalectomy Cure 0.8 Cure 
3 56 F Right - Y Medical Improved - - 
4 64 F Right Y Y Adrenalectomy Improved 1.3 - 
5 41 M Right N N Adrenalectomy Improved NH Improved 
6 48 M Left Y N Adrenalectomy Cure 0.5 Cure 
7 46 M Left Y N Adrenalectomy Cure 0.8 Cure 
8 52 M Right Y N Adrenalectomy Improved 1.8 - 
9 54 M Right N Y Medical Improved - - 
10 56 M Left Y Y Adrenalectomy Improved 1.8, 1.0 Cure 
11 42 M Bilat N N Adrenalectomy Improved NH - 
12 54 M Bilat Y Y Medical Improved - - 
13 57 F Bilat - N Medical Improved - - 
14 55 F Bilat N N Medical Improved - - 
15 21 M Bilat - N Medical Improved - - 
16 57 F Bilat Y Y Adrenalectomy Improved 0.8 - 
17 47 F Bilat N Y Medical Improved - - 
18 59 M Bilat Y Y Adrenalectomy Improved 1.0 - 
19 55 M Unsuccessful Y Y Adrenalectomy Improved 1.8 - 
20 61 M Low Y Y Medical Improved - - 
21 35 M Low N N Medical Improved - - 
22 49 M Unsuccessful N N Medical Improved - - 
23 58 F - Y Y Adrenalectomy Improved 1.8 - 
24 47 M - Y Y Adrenalectomy Cure NH Cure 
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25 54 F - Y Y Adrenalectomy Improved 2.0 - 
26 53 M - Y Y Adrenalectomy Cure 1.0 Cure 
27 61 F - N N Medical Improved - - 
28 56 F - Y Y Medical Improved - - 
29 64 M - N Y Medical Improved - - 
30 45 M - - Y Medical Improved - - 
31 38 M - Y N Medical Improved - - 
32 60 M - - N Medical Improved - - 
33 58 F - N N Medical Improved - - 
34 45 M - - Y Medical Improved - - 
35 52 M - Y Y Medical Not Improved - - 
36 55 M - N N Medical Improved - - 
37 46 F - Y N Medical Improved - - 
*”Right/Left” indicates AVS lateralised to one side, “Bilat” indicates bilateral production, “Low” indicates bilaterally low A/F ratios, 254 
“Unsuccessful” indicates that one side was not successfully cannulated. 255 
+”Y” indicates abnormal appearances on an adrenal CT consistent with an adenoma, on the same side if AVS “lateralised. 256 
# “Medical” indicates treatment with specific aldosterone blocking drug; spironolactone, amiloride or both. 257 
×”NH” indicates nodular hyperplasia. 258 
†
"Cure" indicates normal suppression of plasma aldosterone during postoperative fludrocortisone suppression testing, "Improved" 259 
indicates failure of normal suppression of plasma aldosterone during postoperative FST (consistent with residual autonomous aldosterone 260 
production) but with day four FST plasma aldosterone levels lower than pre-operatively. 261 
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Reviewers’ Summary Evaluations 
 
 
 
 
Referee 1 
Adrenal sampling (AVS) is an essential tool in assessment of primary aldosteronism (PA) in 
order to diagnose an aldosterone-producing adenoma (APA) suitable form for surgery. When 
the aldosterone/cortisol (A/F) ratio is lower bilaterally than peripheral, AVS should be 
repeated; the Authors showed high incidence of APAs in patients with prior AVS incomplete, 
suggesting the significance of repeat AVS. 
 
 
 
 
 
 
Referee 2 
Primary aldosteronism is a frequent cause of identifiable and resistant hypertension. Screening 
for this potentially curable disorder has evolved with better endocrinologic criteria and adrenal 
imaging. Laparoscopic surgery is highly effective for excision of Conn’s tumors. However, 
surgical cure depends on pre-operative localization, by adrenal venous sampling, to avoid 
‘wrong-side’ surgery.  The summary by Wolley et al of their very large series tells an important 
lesson: “If at first, you don’t succeed, try, and try again.” However, the expertise that a large 
experience conveys implies that interventional management of primary aldosteronism is best 
conducted in appropriate referral centers.  
 
 
 
 
 
Reviewer strengths and weaknesses (JOURNAL OFFICE USE ONLY)
Condensed abstract 
This retrospective observational study of adrenal vein sampling (AVS) for primary 
aldosteronism reviewed 1397 AVS done with consistent protocols over a 34 year period to 
examine the frequency of cases where adequate samples were obtained but bilaterally low 
aldosterone production was demonstrated. This occurred in 37 (2.6%) cases and 22 of these 
underwent a repeat study, demonstrating 10 unilateral aldosterone producing adenoma 
(APA), 8 cases of bilateral disease and 4 inconclusive repeat studies. Since the incidence of 
APA was high in this subgroup, these patients should always be offered a repeat AVS. 
 
*Condensed abstract
Abbreviations definitions list 
 
PA = Primary aldosteronism 
AVS = Adrenal vein sampling 
APA = Aldosterone producing adenoma 
A/F ratio = Aldosterone/cortisol ratio 
ACTH = Adrenocorticotrophic hormone 
CT = Computed tomography 
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